Astera Labs (NASDAQ:ALAB - Get Free Report) is projected to release its Q3 2026 results after the market closes on Tuesday, November 3rd. Analysts expect the company to post earnings of $1.19 per share and revenue of $550.78 million for the quarter. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Interested persons are encouraged to explore the company's upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 4:30 PM ET.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. Astera Labs's revenue for the quarter was up 104.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.44 earnings per share. On average, analysts expect Astera Labs to post $2.71 EPS for the current fiscal year and $4.56 EPS for the next fiscal year.
Astera Labs Stock Up 0.9%
NASDAQ:ALAB opened at $259.51 on Tuesday. The company has a market cap of $45.02 billion, a P/E ratio of 128.47 and a beta of 3.68. The firm's 50 day moving average is $310.76 and its two-hundred day moving average is $252.11. Astera Labs has a fifty-two week low of $97.89 and a fifty-two week high of $499.48.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on ALAB. Royal Bank Of Canada boosted their price objective on shares of Astera Labs from $425.00 to $500.00 and gave the company an "outperform" rating in a research note on Wednesday, August 5th. Jefferies Financial Group increased their target price on Astera Labs from $270.00 to $450.00 and gave the stock a "buy" rating in a research report on Wednesday, August 5th. TD Cowen reduced their target price on Astera Labs from $375.00 to $300.00 and set a "hold" rating on the stock in a report on Monday, October 19th. Barclays lifted their target price on Astera Labs from $200.00 to $325.00 and gave the company an "equal weight" rating in a report on Monday, July 20th. Finally, Northland Securities downgraded Astera Labs from an "outperform" rating to a "market perform" rating in a research report on Friday, October 9th. Eleven research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $340.79.
Get Our Latest Stock Analysis on Astera Labs
Insider Buying and Selling
In other news, CEO Jitendra Mohan sold 90,630 shares of the company's stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares of the company's stock, valued at $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief operating officer owned 1,119,038 shares of the company's stock, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 408,558 shares of company stock valued at $127,306,034 over the last ninety days. Insiders own 10.40% of the company's stock.
About Astera Labs
(
Get Free Report)
Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.
The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.